Published Date: 31 Mar 2023
Today's top news includes: Studies show that replacing phthalates can harm brain development and health.
Read Full NewsBreast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether ...
The periodization of exercise training could give people undergoing cancer treatment and those in recovery a tailored pathway to support strength and resilience during the challenging journey of cancer care and rehabilitation.
A new clinical trial led by University of Alberta researchers is exploring whether heavy strength training is a safe and beneficial way to help combat the long-term physical challenges faced by head and neck cancer survivors.
1.
Check for eating disorders in bipolar disorder patients.
2.
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?
3.
New drug combination shows particularly good results in patients with HPV-negative head and neck cancer
4.
According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.
5.
Medical Journal March 29, 2023
1.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
2.
Introduction to Immune Thrombocytopenic Purpura
3.
How HLH is Revolutionizing Healthcare
4.
The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside
5.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XII
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation